Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel rigid framework catalyst solving racemization issues. Enables asymmetric cyclization with >99% ee. Reliable supply for pharma intermediates.
Patent CN103524359B reveals high ee value synthesis using epichlorohydrin. Offers significant cost reduction and supply reliability for asymmetric catalysis manufacturing processes.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.
Patent CN116041393B reveals a novel N-N axis chiral ligand offering superior stereoselectivity and cost-effective synthesis for asymmetric catalysis applications.
Patent CN113248422A details a visible-light catalyzed method for chiral azaarenes, offering green synthesis and high enantioselectivity for pharmaceutical intermediates.
Novel patent CN116655616B reveals efficient synthesis for chiral ligands enabling cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing processes.
Patent CN116283527B reveals nickel-catalyzed tetralone synthesis offering high purity and cost efficiency for scalable pharmaceutical intermediates manufacturing supply chains.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole intermediates with superior purity and scalability.
Patent CN102040594A introduces a recyclable chiral bisoxazoline ligand with imidazolium salts, offering superior enantioselectivity and stability for pharmaceutical intermediate manufacturing.
Novel quinoline-substituted bisoxazoline ligand enables high enantioselectivity in trifluoromethylation. Offers scalable synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand synthesis offering superior stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN109265385B discloses a low-cost, high-yield synthesis of chiral diphenyl prolinol using sulfuric acid catalysis, offering significant supply chain advantages.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Patent CN111233852A discloses a benzoisofuran-based ligand for asymmetric fluorination, offering mild conditions and high stereoselectivity for pharmaceutical intermediate manufacturing.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN114315609A discloses a novel 3-step process for cis-2-aminocyclohexanol from cyclohexene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Delivers high optical purity and cost reduction in fine chemical manufacturing for global supply chains.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.